| Study suggests that miR-135a may function as a tumor suppressor via targeting JAK to repress p-STAT3 activation, reduce cyclin D1 and Bcl-xL expression and inhibit gastric cancer cell proliferation. | gastric, |
| The results demonstrate that miR-135a targets Bmi1 in pancreatic ductal adenocarcinoma and functions as a tumor suppressor. | pancreatic, |
| miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1 | gastric, |
| Study demonstrates that miR-135a regulates cell proliferation in breast cancer by targeting ELK1 and ELK3 oncogenes, and suggests that miR-135a potentially can act as a tumor suppressor. | breast, |
| miR-135a-3p serves as a tumour suppressor gene in ovarian cancer by regulating CCR2. | ovarian, |
| the results of the present study provided evidence that miR135 acted as a tumor suppressor in breast cancer. | breast, |
| miR-135a acts as a tumor suppressor by targeting ASPH in endometrial cancer | endometrial, |
| Proliferation and apoptosis assays demonstrated that miR-181a/135a/302c function as tumor suppressors via repressing PLAG1/IGF2 signaling. | None |
| MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. | colorectal, |